# A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

> **NCT05421611** · PHASE3 · COMPLETED · sponsor: **Serum Institute of India Pvt. Ltd.** · enrollment: 1824 (actual)

## Conditions studied

- Yellow Fever

## Interventions

- **BIOLOGICAL:** STAMARIL
- **BIOLOGICAL:** SII-YFV

## Key facts

- **NCT ID:** NCT05421611
- **Lead sponsor:** Serum Institute of India Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-11
- **Primary completion:** 2024-05-10
- **Final completion:** 2024-05-10
- **Target enrollment:** 1824 (ACTUAL)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05421611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05421611, "A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05421611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*